Thomas V. Johnson III, MD, PhD, is a glaucoma specialist, neuroscientist, and the Shelley and Allan Holt Rising Professor of Ophthalmology at Wilmer Eye Institute in Philadelphia. In this session from Glaucoma Research Foundation's 2024 Patient Summit, Dr. Johnson presents an update on cutting-edge glaucoma research from his laboratory at Johns Hopkins focused on developing the next generation of new and better treatments for glaucoma. He is introduced by L. Jay Katz, MD, FACS. Learn more at https://glaucoma.org